SCHEMBL596252

SCHEMBL596252

O=C1CCCCN1Cc1ccccc1

nearest known ligand 0.96

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.96
HRH3 Q9Y5N1 2/20 0.66
ACHE P22303 1/20 0.62
KMT2A Q03164 3/20 0.56
MEN1 O00255 2/20 0.56
GAA P10253 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
DDB1 Q16531 1/20 0.53
CRBN Q96SW2 1/20 0.53
ACACB O00763 1/20 0.51
KCNH2 Q12809 1/20 0.49
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
HTT P42858 1/20 0.47
POLB P06746 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
APP P05067 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1626076 0.98 L3MBTL1 (1.00) L3MBTL1HRH3ACHEKMT2AMEN1
SCHEMBL7269112 0.98 L3MBTL1 (1.00) L3MBTL1HRH3ACHEKMT2AMEN1
SCHEMBL9212361 0.98 L3MBTL1 (1.00) L3MBTL1HRH3ACHEKMT2AMEN1
SCHEMBL610772 0.98 L3MBTL1 (1.00) L3MBTL1HRH3ACHEKMT2AMEN1
SCHEMBL8903528 0.96 L3MBTL1 (0.97) L3MBTL1HRH3ACHEKMT2AMEN1
Hydrochloric Acid SCHEMBL12494696 0.96 L3MBTL1 (0.97) L3MBTL1HRH3ACHEKMT2AMEN1
SCHEMBL180739 0.94 L3MBTL1 (0.86) L3MBTL1HRH3ACHEKMT2AMEN1
Hydrochloric Acid SCHEMBL6818365 0.93 L3MBTL1 (0.83) L3MBTL1HRH3ACHEKMT2AMEN1
SCHEMBL24938208 0.90 L3MBTL1 (0.84) L3MBTL1HRH3ACHEKMT2AMEN1
Bicarbonate SCHEMBL5329298 0.89 L3MBTL1 (0.78) L3MBTL1HRH3ACHEKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 613 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119241422-A Preparation method of 1-benzyl-4-amino-4-piperidinecarboxylic acid 安庆百谊生物科技有限公司 2025-01-03 CN claimed
CN-118125969-A Haloperidol with excellent biological performance and preparation method and application thereof 湖南洞庭药业股份有限公司 2024-06-04 CN claimed
CN-116144173-A Reinforced PA56/PA6 composite material for rapid prototyping cycle engine cover plate and preparation method thereof 广州海天塑胶有限公司 2023-05-23 CN claimed
CN-115850156-A Method for purifying difluoride compound 上海泰坦科技股份有限公司 2023-03-28 CN claimed
CN-115754076-A Gas chromatography for measuring related substances in 4-methylene piperidine hydrochloride 江苏恒盛药业有限公司 2023-03-07 CN claimed
CN-115626925-A Synthesis method of bispidine 山东汇海医药化工有限公司 2023-01-20 CN claimed
CN-218166172-U Wet product drying and filter pressing device for N-benzyl piperidone production 安徽中山化工有限公司 2022-12-30 CN claimed
CN-115322567-B Non-buckling-deformation reinforced heat-conducting nylon material and preparation method thereof 广州海天塑胶有限公司 2022-12-27 CN claimed
CN-115322567-A Non-buckling-deformation reinforced heat-conducting nylon material and preparation method thereof 广州海天塑胶有限公司 2022-11-11 CN claimed
US-20180326407-A1 Olefin polymerization catalyst components and process for the production of olefin polymers therewith FORMOSA PLASTICS CORPORATION, USA 2018-11-15 US claimed
WO-2009021943-A2 NOVEL PREPARATION PROCESS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-02-19 WO claimed
WO-2008099198-A2 OSTEOGENIC COMPOUNDS INION LIMITED (GB) 2008-08-21 WO claimed
WO-2008022962-A2 METHOD FOR PRODUCING N-PIPERIDINYL-BENZODIAZEPINES HAVING CGRP-ANTAGONISTIC PROPERTIES BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-02-28 WO claimed
US-20080045705-A1 Production Method BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-02-21 US claimed
EP-0710238-A1 METHOD OF PREPARING N,N'-DIBENZYLBISPIDINE BASF AKTIENGESELLSCHAFT (DE) 1996-05-08 EP claimed
WO-1995002599-A1 METHOD OF PREPARING N,N'-DIBENZYLBISPIDINE BASF AKTIENGESELLSCHAFT (DE) 1995-01-26 WO claimed
EP-0328830-B1 4-Heteropentacyclic-4- N-(phenyl)amido piperidine compounds OHMEDA PHARMA PROD (US) 1994-06-01 EP claimed
EP-0011057-B1 PROCESS FOR THE PREPARATION OF VINCADIFFORMINE AND DERIVATIVES THEREOF, INTERMEDIATES OBTAINED DURING THIS PROCESS AND PROCESS FOR THEIR PREPARATION OMNICHEM Société anonyme (BE) 1983-02-09 EP claimed
US-4267330-A CONDENSATION OF A HALO-, SULFOAKLOXY-, OR OPOXYALDEHYDE WITH A DIALKYL 1,2,3,4,5,6-HEXAHYDROAZEPINO/4,5-B/INDOLE-5,5-DICARBOXYLATE; ALKALOIDS OMNIUM CHIMIQUE SOCIETE ANONYME (BE) 1981-05-12 US claimed
EP-0011057-A1 Process for the preparation of vincadifformine and derivatives thereof, intermediates obtained during this process and process for their preparation OMNICHEM Société anonyme (BE) 1980-05-14 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045705-A1 Production Method CYP2F1, CYP7A1, CYP1A1 L3MBTL1 4239/4885HRH3 2175/4885ACHE 1362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.